JS, Z., & J, J. (2025). ASO Author Reflections: Percutaneous Hepatic Perfusion with Melphalan/Hepatic Delivery System Versus Best Alternative Care for Patients with Metastatic Uveal Melanoma. Annals of surgical oncology, 32(8), 5404. https://doi.org/10.1245/s10434-025-17614-0
Chicago Style (17th ed.) CitationJS, Zager, and John J. "ASO Author Reflections: Percutaneous Hepatic Perfusion with Melphalan/Hepatic Delivery System Versus Best Alternative Care for Patients with Metastatic Uveal Melanoma." Annals of Surgical Oncology 32, no. 8 (2025): 5404. https://doi.org/10.1245/s10434-025-17614-0.
MLA (9th ed.) CitationJS, Zager, and John J. "ASO Author Reflections: Percutaneous Hepatic Perfusion with Melphalan/Hepatic Delivery System Versus Best Alternative Care for Patients with Metastatic Uveal Melanoma." Annals of Surgical Oncology, vol. 32, no. 8, 2025, p. 5404, https://doi.org/10.1245/s10434-025-17614-0.